Neurofilament light chain (NfL) has emerged as a promising blood biomarker for the
progression of various neurological diseases. NfL is a structural protein of nerve cells, and …

Abstract Background and Aims Neurofilament light chain (NfL) is an emerging biomarker of
neurodegenerative disease progression. As plasma NfL increases with age …

Background Blood biomarkers can offer valuable and easily accessible indicators of normal
biological processes, pathogenic conditions, and responses to therapeutic interventions …

Previous studies demonstrated that plasma neurofilament light chain (NFL) played important
predictive roles in disease progression and neurodegeneration in the preclinical phase of …

Over the past several years, there has been a surge in blood biomarker studies examining
the value of plasma or serum neurofilament light (NfL) as a biomarker of neurodegeneration …

Objective Neuronal damage is the morphological substrate of persisting neurological
disability. Neurofilaments (Nf) are cytoskeletal proteins of neurons and their release into …

Background Blood-based neurofilament light chain (NfL) is a promising biomarker of
neurodegeneration across multiple neurodegenerative diseases. However, blood-based …

Objective Early identification of cognitive impairment in neurodegenerative diseases like
Alzheimer's disease (AD) is crucial. Neurofilament, a potential biomarker for neurological …

Neurofilament light chain (NfL) is a novel biomarker of neurodegenerative diseases. It is
detectable in the peripheral blood, allowing low-invasive assessment of early signs of …

Neurofilament light (NfL) protein is a marker of neuro-axonal damage and can be measured
not only in cerebrospinal fluid but also in serum, which allows for repeated assessments …